Viva Biotech

Viva Biotech Holdings, headquartered in Shanghai, is a premier global service provider offering integrated solutions for drug discovery, development, and manufacturing. Since its inception in 2008, the company has supported biopharmaceutical innovators worldwide, leveraging cutting-edge technology and deep expertise.

Viva Biotech specialises in structure-based drug discovery (SBDD) and supports the entire drug development lifecycle, from early-stage R&D to commercial manufacturing. Its offerings span from hit identification and lead optimisation to drug substance and product manufacturing. Viva Biotech's synergistic integration of its CRO and CDMO capabilities allows clients to streamline development timelines and accelerate therapeutic innovations.

In addition to contract services, Viva Biotech operates a unique equity-for-service (EFS) business model, investing in early-stage biotech companies globally. As of 2022, the company has invested in 91 portfolio companies, fostering innovation while expanding its influence in the biopharma ecosystem.

Key Products and Services:

1. Drug Discovery Services (CRO):
   • Structure-based drug design (SBDD)
   • Cryo-EM and X-ray crystallography
   • Computer-aided drug design (CADD) with AI integration
   • PROTAC research and high-throughput screening
   • Medicinal and synthetic chemistry
2. Manufacturing Services (CDMO):
   • Drug substance and product manufacturing
   • Process development and GMP-compliant production
3. Equity-for-Service (EFS) Investment Model:
   • Supporting start-ups with R&D services in exchange for equity stakes
4. Technology Platforms:
   • PROTAC, membrane protein research, Cryo-EM, and AI-assisted platforms

Facilities and Operations:
Viva Biotech has state-of-the-art facilities across China, including a supercomputing centre and laboratories in Shanghai, Chengdu, Suzhou, and Hangzhou. The company employs over 2,600 staff, with over 1,600 dedicated to R&D roles, reflecting its commitment to innovation and customer success.

Viva Biotech is committed to fostering a win-win ecosystem for biopharmaceutical innovators. By bridging the gap between early-stage discovery and large-scale manufacturing, it continues to solidify its reputation as a trusted partner in the global biopharma industry​.